{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:16:28Z","timestamp":1754194588931,"version":"3.41.2"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T00:00:00Z","timestamp":1600473600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/open-government-licence\/version\/2\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U24 AA020794","U01 AA020790","U10 AA013566","T35HL007649"],"award-info":[{"award-number":["U24 AA020794","U01 AA020790","U10 AA013566","T35HL007649"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Case reports describe incident sarcoidosis in persons with HIV (PWH). The association between HIV and risk of sarcoidosis, and differences in presentation in PWH, have not been systematically assessed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Subjects were selected from the Veterans Aging Cohort Study (VACS), a longitudinal cohort study including veterans with HIV and matched uninfected veterans. This was a prospective observational analysis in which we evaluated both the incidence (via incidence rate ratio) and presentation and treatment (by comparison of rates of organ involvement and use of medications) of sarcoidosis in PWH compared with HIV-negative controls. We also assessed risk factors (via Cox regression) associated with the development of sarcoidosis including CD4 count and viral load trajectory.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 1614 patients evaluated via chart review, 875 (54%) had prevalent sarcoidosis and 325 (20%) had confirmed incident sarcoidosis. Incident sarcoidosis occurred in 59 PWH and 266 uninfected. The incidence of sarcoidosis was lower in PWH than uninfected (incidence rate ratio [IRR], 0.61; 95% CI, 0.46\u20130.81) and especially low in patients with unsuppressed viremia (IRR, 0.04; 95% CI, 0.02\u20130.08) compared with uninfected). At diagnosis of sarcoidosis, the median CD4 count among PWH was 409 cells\/mm3; 77% had HIV-1 RNA\u2005&amp;lt;500 copies\/mL. No significant differences were observed between PWH and uninfected in terms of organ involvement, disease severity, or use of oral glucocorticoids.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>HIV, particularly with persistent viremia, was associated with decreased risk of incident sarcoidosis; severity and treatment were similar between PWH and uninfected.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofaa441","type":"journal-article","created":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T02:54:26Z","timestamp":1600484066000},"source":"Crossref","is-referenced-by-count":4,"title":["Incidence and Presentation of Sarcoidosis With and Without HIV Infection"],"prefix":"10.1093","volume":"7","author":[{"given":"Jennifer S","family":"Hanberg","sequence":"first","affiliation":[{"name":"Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA"},{"name":"VA Connecticut Healthcare System, West Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M","family":"Akg\u00fcn","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA"},{"name":"VA Connecticut Healthcare System, West Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5018-8409","authenticated-orcid":false,"given":"Evelyn","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA"},{"name":"VA Connecticut Healthcare System, West Haven, Connecticut, USA"},{"name":"Section of Rheumatology, Yale University School of Medicine, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liana","family":"Fraenkel","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA"},{"name":"VA Connecticut Healthcare System, West Haven, Connecticut, USA"},{"name":"Section of Rheumatology, Yale University School of Medicine, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0139-5502","authenticated-orcid":false,"given":"Amy C","family":"Justice","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA"},{"name":"VA Connecticut Healthcare System, West Haven, Connecticut, USA"},{"name":"Yale University School of Public Health, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"key":"2020102106545757400_CIT0001","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/MCP.0000000000000080","article-title":"Morbidity and mortality in sarcoidosis","volume":"20","author":"Gerke","year":"2014","journal-title":"Curr Opin Pulm Med"},{"key":"2020102106545757400_CIT0002","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s13244-016-0495-4","article-title":"Clinical and radiological features of extra-pulmonary sarcoidosis: a pictorial essay","volume":"7","author":"Palmucci","year":"2016","journal-title":"Insights Imaging"},{"key":"2020102106545757400_CIT0003","first-page":"325","article-title":"Sarcoidosis: a review for the internist","volume":"13","author":"Bargagli","year":"2018","journal-title":"Intern Emerg Med"},{"key":"2020102106545757400_CIT0004","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1513\/pats.200606-130MS","article-title":"Role of CD4+ T cells in sarcoidosis","volume":"4","author":"Grunewald","year":"2007","journal-title":"Proc Am Thorac Soc"},{"key":"2020102106545757400_CIT0005","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/pmj.79.935.535","article-title":"Sarcoidosis and HIV infection: a case report and a review of the literature","volume":"79","author":"Trevenzoli","year":"2003","journal-title":"Postgrad Med J"},{"key":"2020102106545757400_CIT0006","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1378\/chest.124.3.929","article-title":"Sarcoidosis following HIV infection: evidence for CD4+ lymphocyte dependence","volume":"124","author":"Morris","year":"2003","journal-title":"Chest"},{"key":"2020102106545757400_CIT0007","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jinf.2005.05.009","article-title":"Coexistent sarcoidosis and HIV infection: an immunological paradox?","volume":"52","author":"Almeida","year":"2006","journal-title":"J Infect"},{"key":"2020102106545757400_CIT0008","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tube.2016.02.010","article-title":"HIV-1 and the Mycobacterium tuberculosis granuloma: a systematic review and meta-analysis","volume":"98","author":"Diedrich","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"key":"2020102106545757400_CIT0009","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/01.mlr.0000223670.00890.74","article-title":"Development and verification of a \u201cvirtual\u201d cohort using the National VA Health Information System","volume":"44","author":"Fultz","year":"2006","journal-title":"Med Care"},{"key":"2020102106545757400_CIT0010","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/01.mlr.0000223741.02074.66","article-title":"Veterans Aging Cohort Study (VACS): overview and description","volume":"44","author":"Justice","year":"2006","journal-title":"Med Care"},{"key":"2020102106545757400_CIT0011","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00408-017-0054-x","article-title":"Accuracy of diagnostic coding for sarcoidosis in electronic databases: a population-based study","volume":"195","author":"Ungprasert","year":"2017","journal-title":"Lung"},{"key":"2020102106545757400_CIT0012","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mayocp.2015.10.024","article-title":"Epidemiology of sarcoidosis 1946\u20132013: a population-based study","volume":"91","author":"Ungprasert","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"2020102106545757400_CIT0013","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","article-title":"Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years\u2019 observation","volume":"2","author":"Scadding","year":"1961","journal-title":"Br Med J"},{"key":"2020102106545757400_CIT0014","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.mayocpiqo.2019.04.006","article-title":"Clinical manifestations, diagnosis, and treatment of sarcoidosis","volume":"3","author":"Ungprasert","year":"2019","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"2020102106545757400_CIT0015","first-page":"19","article-title":"The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2020102106545757400_CIT0016","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1573399811666150615145824","article-title":"Targeting TNF-alpha in HIV-1 infection","volume":"17","author":"Kumar","year":"2016","journal-title":"Curr Drug Targets"},{"key":"2020102106545757400_CIT0017","doi-asserted-by":"crossref","first-page":"447","DOI":"10.7326\/0003-4819-133-6-200009190-00013","article-title":"Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy","volume":"133","author":"DeSimone","year":"2000","journal-title":"Ann Intern Med"},{"key":"2020102106545757400_CIT0018","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1440-1843.2008.01468.x","article-title":"Pulmonary complications of immune reconstitution inflammatory syndromes in HIV-infected patients","volume":"14","author":"Crothers","year":"2009","journal-title":"Respirology"},{"key":"2020102106545757400_CIT0019","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/381094","article-title":"Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy","volume":"38","author":"Foulon","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2020102106545757400_CIT0020","first-page":"49","article-title":"Immune reconstitution inflammatory syndrome in HIV-infected patients","volume":"7","author":"Walker","year":"2015","journal-title":"HIV AIDS (Auckl)"},{"key":"2020102106545757400_CIT0021","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/QAI.0b013e3182a9215a","article-title":"HIV infection is associated with reduced pulmonary diffusing capacity","volume":"64","author":"Crothers","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020102106545757400_CIT0022","article-title":"Epidemiology and presentation of sarcoidosis with and without HIV infection [abstract]","volume":"71","author":"Hanberg","year":"2019","journal-title":"Arthritis Rheumatol"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaa441\/33771126\/ofaa441.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/7\/10\/ofaa441\/33975031\/ofaa441.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/7\/10\/ofaa441\/33975031\/ofaa441.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T10:56:11Z","timestamp":1603277771000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaa441\/5908749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaa441","relation":{},"ISSN":["2328-8957"],"issn-type":[{"type":"electronic","value":"2328-8957"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,9,18]]},"article-number":"ofaa441"}}